Recurrent Gastric Cancer Completed Phase 2 Trials for IT-101 (DB05899)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

DBCOND0028800 (Recurrent Gastric Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT01612546Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by SurgeryTreatment